The anterior-to-psoas approach for interbody fusion at the L5-S1 segment: clinical and radiological outcomes.

ALIF = anterior lumbar interbody fusion ATP ATP = anterior to psoas DDD = degenerative disc disease LBP = low-back pain LLIF = lateral lumbar interbody fusion ODI = Oswestry Disability Index OLIF OLIF = oblique lumbar interbody fusion PI-LL = pelvic incidence–lumbar lordosis SF-36 = 36-Item Short Form Health Survey VAS = visual analog scale anterior approaches anterior-to-psoas approach degenerative lumbar diseases minimally invasive surgery oblique lumbar interbody fusion

Journal

Neurosurgical focus
ISSN: 1092-0684
Titre abrégé: Neurosurg Focus
Pays: United States
ID NLM: 100896471

Informations de publication

Date de publication:
09 2020
Historique:
received: 29 04 2020
accepted: 10 06 2020
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 20 8 2021
Statut: ppublish

Résumé

Over the last few decades, many surgical techniques for lumbar interbody fusion have been reported. The anterior-to-psoas (ATP) approach is theoretically supposed to benefit from the advantages of both anterior and lateral approaches with similar complication rates, even in L5-S1. At this segment, the anterior lumbar interbody fusion (ALIF) requires retroperitoneal dissection and retraction of major vessels, whereas the iliac crest does not allow the lateral transpsoas approach. This study aimed to investigate clinical-radiological outcomes and complications of the ATP approach at the L5-S1 segment in a single cohort of patients. This is a prospective single-center study, conducted from 2016 to 2019. Consecutive patients who underwent ATP at the L5-S1 segment for degenerative disc disease or revision surgery after previous posterior procedures were considered for eligibility. Complete clinical-radiological documentation and a minimum follow-up of 12 months were set as inclusion criteria. Clinical patient-reported outcomes, such as the visual analog scale for low-back pain, Oswestry Disability Index, and 36-Item Short Form Health Survey (SF-36) scores, as well as spinopelvic parameters, were collected preoperatively, 6 weeks after surgery, and at the last follow-up visit. Intraoperative and perioperative complications were recorded. The fusion rate was evaluated on CT scans obtained at 12 months postoperatively. Thirty-two patients met the inclusion criteria. The mean age at the time of surgery was 57.6 years (range 44-75 years). The mean follow-up was 33.1 months (range 13-48 months). The mean pre- and postoperative visual analog scale (7.9 ± 1.3 vs 2.4 ± 0.8, p < 0.05), Oswestry Disability Index (52.8 ± 14.4 vs 22.9 ± 6.0, p < 0.05), and SF-36 (37.3 ± 5.8 vs 69.8 ± 6.1, p < 0.05) scores significantly improved. The mean lumbar lordosis and L5-S1 segmental lordosis significantly increased after surgery. The mean pelvic incidence-lumbar lordosis mismatch and pelvic tilt significantly decreased. No intraoperative complications and a postoperative complication rate of 9.4% were recorded. The fusion rate was 96.9%. One patient needed a second posterior revision surgery for residual foraminal stenosis. In the present case series, ATP fusion for the L5-S1 segment has resulted in valuable clinical-radiological outcomes and a relatively low complication rate. Properly designed clinical and comparative trials are needed to further investigate the role of ATP for different L5-S1 conditions.

Identifiants

pubmed: 32871565
doi: 10.3171/2020.6.FOCUS20335
pii: 2020.6.FOCUS20335
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E14

Auteurs

Massimo Miscusi (M)

1Department of Neuroscience, Mental Health, and Sense Organs, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome.

Sokol Trungu (S)

1Department of Neuroscience, Mental Health, and Sense Organs, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome.
2Neurosurgery Unit, Cardinal G. Panico Hospital, Tricase; and.

Luca Ricciardi (L)

1Department of Neuroscience, Mental Health, and Sense Organs, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome.
2Neurosurgery Unit, Cardinal G. Panico Hospital, Tricase; and.

Stefano Forcato (S)

2Neurosurgery Unit, Cardinal G. Panico Hospital, Tricase; and.

Alessandro Ramieri (A)

3Department of Orthopedics, Faculty of Pharmacy and Medicine, "Sapienza" University of Rome, Italy.

Antonino Raco (A)

1Department of Neuroscience, Mental Health, and Sense Organs, "Sapienza" University of Rome, Sant'Andrea Hospital, Rome.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH